Patent holdings for IPC class A61K 31/5025

Total number of patents in this class: 2365

10-year publication summary

119
145
154
150
203
188
187
218
256
131
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4897
58
F. Hoffmann-La Roche AG
7920
39
Novartis AG
10927
38
Janssen Pharmaceutica N.V.
3432
35
Takeda Pharmaceutical Company Limited
2703
32
Genentech, Inc.
3954
30
Gilead Sciences, Inc.
2026
30
AstraZeneca AB
2928
27
Boehringer Ingelheim International GmbH
4701
27
Nihon Nohyaku Co., Ltd.
317
25
Agios Pharmaceuticals, Inc
218
23
Pfizer Inc.
3358
21
Hoffmann-La Roche Inc.
3369
20
Vanderbilt University
1886
20
Amgen Inc.
4037
19
Merck Sharp & Dohme LLC
3739
18
Remix Therapeutics Inc.
79
17
Bayer Pharma AG
1061
16
Incyte Corporation
1005
16
Merck Patent GmbH
5840
15
Other owners 1839